China Sky One Medical (中国天字一号医药公司) received SFDA approvals for two new products, both topically applied: Geranium ointment for skin problems such as eczema and Musk liniment for pain relief.  China Sky One said that the products have only one or two competitors on the market. It expects them to generate $800,000 in revenue during 2009 and substantially more in 2010. More details...

Stock Symbol: (NSDQ: CSKI)